Monopar Therapeutics Inc.
MNPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $127,677 | $39,502 | $39,711 | $45,816 |
| Short-Term Investments | $15,998 | $13,748 | $14,841 | $14,396 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $415 | $497 | $524 | $79 |
| Total Curr. Assets | $144,090 | $53,748 | $55,076 | $60,291 |
| Property Plant & Equip (Net) | $107 | $118 | $9 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $107 | $118 | $9 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $144,197 | $53,866 | $55,085 | $60,291 |
| Liabilities | – | – | – | – |
| Payables | $2,537 | $1,584 | $1,492 | $2,254 |
| Short-Term Debt | $31 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $3,000 |
| Total Curr. Liab. | $2,569 | $1,584 | $1,492 | $5,254 |
| LT Debt | $71 | $80 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $0 | $0 |
| Total NC Liab. | $71 | $80 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $102 | $80 | $0 | $0 |
| Total Liabilities | $2,640 | $1,664 | $1,492 | $5,254 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $7 | $6 | $6 | $6 |
| Retained Earnings | -$84,309 | -$80,871 | -$78,418 | -$75,793 |
| AOCI | $12 | $78 | -$22 | $36 |
| Other Equity | $225,847 | $132,989 | $132,027 | $130,787 |
| Total Equity | $141,557 | $52,202 | $53,593 | $55,037 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $144,197 | $53,866 | $55,085 | $60,291 |
| Net Debt | -$127,575 | -$39,422 | -$39,711 | -$45,816 |